Company Profile

Lase Innovation Inc
Profile last edited on: 10/20/2021      CAGE: 89NB1      UEI: LQDAZMN14NM7

Business Identifier: Platform technology for optics
Year Founded
2017
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

85 Bolton Street Suite 105
Cambridge, MA 02140
   (617) 599-0003
   N/A
   laseinnovation.com/
Location: Single
Congr. District: 07
County: Middlesex

Public Profile

LASE Innovation is a startup providing innovative optics solutions for broad applications. Structured around developing to commercial condition, the firm offers laser particle technology: next-generation light-emitting particles with nano-to-micron sizes. Currently targeting life science and diagnostic markets by commercializing LASE Particle (LP) technology -- initially developed at MGH, Harvard and MIT -- the firm's LPs are novel laser-emitting nano/micro particles that - due to their narrow emission - provide orders of magnitude more colors than conventional fluorescent probes for multiplexing and cell tracking applications. It is reported that the company aims to release its first products - including consumable LPs and life science instruments for single-cell analysis.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NIH $1,962,235
Project Title: Cyclic Flow Cytometry for Ultra-High Marker Single-Cell Analysis
2021 1 NIH $253,256
Project Title: Sample Barcoding for Ultra High-Throughput Flow Cytometry
0 1 NIH $1,002,340
Project Title: Time-lapse Flow Cytometry for Kinetic Profiling of T-Cell Function

Key People / Management

  Sarah Forward

  Sheldon J J Kwok

  Sean Vote -- Director of Operations

Company News

There are no news available.